Evidence map›Paper›PMID 40333247›Full record

ArticleVaccines2025

The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based Analysis.

Lin Yuan, Madison Stoddard, Sharanya Sarkar, Debra van Egeren, Shruthi Mangalaganesh, Ryan P Nolan, Michael S Rogers, Greg Hather, Laura F White, Arijit Chakravarty

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lin YuanFractal Therapeutics, Lexington, MA 02420, USA.
Madison StoddardFractal Therapeutics, Lexington, MA 02420, USA.ORCID 0000-0001-9853-8500
Sharanya SarkarDepartment of Microbiology and Immunology, Dartmouth College, Hanover, NH 03755, USA.ORCID 0000-0002-2459-8620
Debra van EgerenDepartment of Oncology, School of Medicine, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-4017-0413
Shruthi MangalaganeshFaculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC 3800, Australia.
Ryan P NolanHalozyme Therapeutics, San Diego, CA 92130, USA.
Michael S RogersDepartment of Surgery, Harvard Medical School, Boston, MA 02114, USA.ORCID 0000-0002-5250-8434
Greg HatherSage Therapeutics, Cambridge, MA 02142, USA.
Laura F WhiteSchool of Public Health, Boston University, Boston, MA 02118, USA.ORCID 0000-0002-0588-8235
Arijit ChakravartyFractal Therapeutics, Lexington, MA 02420, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

agent-based modelingCOVID-19SARS-CoV-2schedulingvaccinationvaccine boosting

Identifiers

PMID40333247
PMCPMC12031506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.